EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.14.13.39 | 1,4-bis-[[2-(dimethylamino-N-oxide)ethyl]amino]-5,8-dihydroxyanthracene-9,10-dione + NADPH |
- |
Homo sapiens |
1-[[2-(dimethylamino-N-oxide)ethyl]amino]-4-[[2-(dimethylamino)ethyl]amino]-5,8-dihydroxyanthracene-9,10-dione + ? |
- |
ir |
1.14.13.39 | 1-butyl-2-hydroxyguanidine + NADPH + O2 |
- |
Rattus norvegicus |
? + NO + NADP+ |
- |
? |
1.14.13.39 | 1-[[2-(dimethylamino-N-oxide)ethyl]amino]-4-[[2-(dimethylamino)ethyl]amino]-5,8-dihydroxyanthracene-9,10-dione + NADPH |
- |
Homo sapiens |
1,4-bis[[2-(dimethylamino)ethyl]amino]-5,8-dihydroxyanthracene-9,10-dione + ? |
- |
ir |
1.14.13.39 | 2 L-arginine + 2 NADPH + 2 H+ + 2 O2 |
first half reaction via intermediate Nomega-hydroxy-L-arginine |
Staphylococcus aureus |
2 Nomega-hydroxy-L-arginine + 2 NADP+ + 2 H2O |
- |
? |
1.14.13.39 | 2 L-arginine + 2 NADPH + 2 H+ + 2 O2 |
first half reaction via intermediate Nomega-hydroxy-L-arginine |
Bacillus subtilis |
2 Nomega-hydroxy-L-arginine + 2 NADP+ + 2 H2O |
- |
? |
1.14.13.39 | 2 L-arginine + 2 NADPH + 2 H+ + 2 O2 |
first half reaction via intermediate Nomega-hydroxy-L-arginine |
Rattus norvegicus |
2 Nomega-hydroxy-L-arginine + 2 NADP+ + 2 H2O |
- |
? |
1.14.13.39 | 2 L-arginine + 2 NADPH + 2 H+ + 2 O2 |
first half reaction via intermediate Nomega-hydroxy-L-arginine with consecutive appearance of heme-dioxy, ferric heme-NO, and ferric heme species, overview |
Drosophila melanogaster |
2 Nomega-hydroxy-L-arginine + 2 NADP+ + 2 H2O |
- |
? |
1.14.13.39 | 2 L-arginine + 2 NADPH + 2 H+ + 2 O2 |
first half reaction |
Homo sapiens |
2 Nomega-hydroxy-L-arginine + 2 NADP+ + 2 H2O |
- |
ir |
1.14.13.39 | 2 L-arginine + 3 NADPH + 3 H+ + 4 O2 |
- |
Staphylococcus aureus |
2 citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O |
- |
? |
1.14.13.39 | 2 L-arginine + 3 NADPH + 3 H+ + 4 O2 |
- |
Bacillus subtilis |
2 citrulline + 2 nitric oxide + 3 NADP+ + 4 H2O |
- |
? |